Stockholm, Sweden

Johan Axelsson

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Blueair Ab. Active years: 2020-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan Axelsson. Retrieved from https://idiyas.com/inventor/johan-axelsson-59527vhx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2020-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Johan Axelsson

Introduction

Johan Axelsson is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of air treatment technology. With a total of two patents to his name, Axelsson's work reflects his commitment to improving air quality and health.

Latest Patents

Among his latest innovations is an air treatment device designed to enhance indoor air quality. This invention showcases his dedication to creating solutions that address environmental and health concerns.

Career Highlights

Throughout his career, Johan Axelsson has worked with prominent companies such as Blueair AB and Med Coat AB. His experience in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Axelsson has collaborated with talented individuals like Fredrik Victorin and Marie Charlotte Ideström. These partnerships have contributed to the success of his projects and inventions.

Conclusion

Johan Axelsson's contributions to air treatment technology highlight his innovative spirit and dedication to improving public health. His work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…